D1,2 q21d: Bendamustine (treanda) +/- Rituximab is typically given days 1 and 2 every 21 days for non-hodgkin's lymphoma (nhl). The dose and frequency are different in cll. Patients often need dose or cycle duration adjustment based on their prior therapies, age, etc. Ref: http://www.Treanda.Com.
Answered 7/1/2014
6.1k views
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
5 doctors weighed in across 2 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question